- Home
- PRTA vs MLAB Comparison
PRTA vs MLAB Comparison
Compare PRTA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MLAB
- Stock Information
- Founded
- PRTA 2012
- MLAB 1982
- Country
- PRTA Ireland
- MLAB United States
- Employees
- PRTA N/A
- MLAB 730
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- PRTA Health Care
- MLAB Industrials
- Exchange
- PRTA Nasdaq
- MLAB Nasdaq
- Market Cap
- PRTA 366.6M
- MLAB 341.1M
- IPO Year
- PRTA N/A
- MLAB N/A
- Fundamental
- Price
- PRTA $7.69
- MLAB $64.29
- Analyst Decision
- PRTA Buy
- MLAB Buy
- Analyst Count
- PRTA 10
- MLAB 2
- Target Price
- PRTA $24.29
- MLAB $113.50
- AVG Volume (30 Days)
- PRTA 955.8K
- MLAB 139.7K
- Earning Date
- PRTA 08-04-2025
- MLAB 08-05-2025
- Dividend Yield
- PRTA N/A
- MLAB 0.99%
- EPS Growth
- PRTA N/A
- MLAB N/A
- EPS
- PRTA N/A
- MLAB N/A
- Revenue
- PRTA $10,341,000.00
- MLAB $242,351,000.00
- Revenue This Year
- PRTA N/A
- MLAB $6.45
- Revenue Next Year
- PRTA $122.46
- MLAB $5.80
- P/E Ratio
- PRTA N/A
- MLAB N/A
- Revenue Growth
- PRTA N/A
- MLAB 8.33
- 52 Week Low
- PRTA $4.32
- MLAB $55.45
- 52 Week High
- PRTA $23.66
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- PRTA 70.62
- MLAB 34.74
- Support Level
- PRTA $6.61
- MLAB $55.45
- Resistance Level
- PRTA $8.01
- MLAB $66.15
- Average True Range (ATR)
- PRTA 0.40
- MLAB 4.50
- MACD
- PRTA 0.10
- MLAB -0.49
- Stochastic Oscillator
- PRTA 81.40
- MLAB 35.43
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.